Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development.
about
Using omics approaches to understand pulmonary diseases.Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset.The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
P2860
Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Proteomic study of acute respi ...... ications for drug development.
@en
type
label
Proteomic study of acute respi ...... ications for drug development.
@en
prefLabel
Proteomic study of acute respi ...... ications for drug development.
@en
P2860
P1476
Proteomic study of acute respi ...... ications for drug development.
@en
P2093
Angela J Rogers
Joseph E Levitt
P2860
P304
P356
10.1586/14789450.2016.1172481
P577
2016-03-31T00:00:00Z